Delivery Order SPE2DB25D7056-SPE2DB25FTMPT
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Moxifloxacin HCL 400 mg tablets (30-count packages) with a contract ceiling value of $1,188.24. This competitively awarded, non-set-aside delivery order carries a firm fixed price and is scheduled for completion by September 15, 2025. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Moxifloxacin HCL 400 mg tablets in unit dose packaging of 50s. This is a firm fixed price delivery order with a ceiling value of $1,852.51 and an ultimate completion date of August 18, 2025. The award was competitively awarded with no set-aside designation, and performance will be executed from the vendor's corporate office in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for moxifloxacin hydrochloride 400 mg tablets in unit dose packaging of 50s, with a ceiling value of $2,070.00. Awarded on August 14, 2025, this firm fixed-price delivery order is due for completion by August 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, consistent with...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Moxifloxacin HCL 400 mg tablets in unit dose packaging of 50 units. The contract is valued at $1,752.82 with a firm fixed price structure and an ultimate completion date of August 8, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $1,500.48 to AmerisourceBergen Drug Corp for the supply of Moxifloxacin HCL 400 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating open competition among...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for moxifloxacin HCl 400 mg tablets (unit dose, 50s) with a ceiling value of $1,380.00. This competitive, non-set-aside contract was awarded on July 31, 2025, with a completion date of August 1, 2025. The order will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, under firm fixed-price terms as a delivery order, indicating this is a fulfillment against an...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Moxifloxacin HCL 400 mg tablets (30-count units) at a firm fixed price ceiling value of $1,498.92. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 15, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Moxifloxacin HCL 400 mg tablets in unit-dose packaging of 50 tablets each. This delivery order, valued at $13,589.23, represents a firm fixed-price contract with an ultimate completion date of August 29, 2025. The award was made on a competitive basis with no set-aside provisions and will be performed at AmerisourceBergen's facility in Conshohocken,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Moxifloxacin HCL 400 mg tablets in unit dose packaging of 50 units. This competitively awarded, non-set-aside contract has a firm fixed price ceiling value of $2,572.99 with an ultimate completion date of August 7, 2025. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of moxifloxacin HCL 400 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $1,265.17 and an ultimate completion date of September 15, 2025. The contract was competitively awarded without any set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place...
- SPE2DB25D7056Indefinite Delivery Contract
- SPE2DB25D7056-SPE2DB25FTMPTDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Moxifloxacin HCL 400 mg tablets (30-count units) with a contract ceiling value of $1,549.46 and an ultimate completion date of June 18, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with no small business designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The Moxifloxacin HCL order supports the Defense Health Agency and other federal healthcare systems' requirements for this fluoroquinolone antibiotic, which is commonly used in military medical treatment facilities for bacterial infections. As a child contract under the larger IDC vehicle, this delivery order exemplifies the efficiency of the indefinite delivery mechanism in meeting routine pharmaceutical supply needs across the federal healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 6/17/25 |